Vekariya, Umeshkumar
Minakhin, Leonid
Chandramouly, Gurushankar
Tyagi, Mrityunjay
Kent, Tatiana
Sullivan-Reed, Katherine
Atkins, Jessica
Ralph, Douglas
Nieborowska-Skorska, Margaret
Kukuyan, Anna-Mariya
Tang, Hsin-Yao http://orcid.org/0000-0003-1838-018X
Pomerantz, Richard T. http://orcid.org/0000-0003-1194-9871
Skorski, Tomasz http://orcid.org/0000-0002-3809-4538
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA244179, R01CA186238, R01CA283396, R01CA244707)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Leukemia and Lymphoma Society (TRP 6628-21)
U.S. Department of Health & Human Services | National Institutes of Health (R01GM137124)
Article History
Received: 29 August 2023
Accepted: 27 June 2024
First Online: 11 July 2024
Competing interests
: R.T.P. is a co-founder and chief scientific officer of Recombination Therapeutics, LLC. The remaining authors declare no competing interests.